Healthcare & Life Sciences

Latham offers life sciences and healthcare industry leaders deep sector knowledge, legal expertise, and commercial and government insight to meet client needs. Companies operating in the healthcare and life sciences sectors face an increasingly complex transactional, political, and competitive landscape. Latham’s superior grasp of the regulatory regimes and market issues means that clients can adroitly and expeditiously address litigation, mergers and acquisitions, capital raising, regulatory counseling, business restructuring and reorganization, contract negotiations, fraud and abuse compliance, white collar and government investigations, operational matters, and more. Global Chairs: John Manthei Judith Hasko

Why Latham

Melding Deep Industry Experience with Commercial Insight

Companies operating in the healthcare and life sciences sectors face an increasingly complex transactional, political, and competitive landscape. Latham’s superior grasp of the regulatory regimes and market issues means that clients can adroitly and expeditiously address litigation, mergers and acquisitions, capital raising, regulatory counseling, business restructuring and reorganization, contract negotiations, fraud and abuse compliance, white collar and government investigations, operational matters, and more.

Learn more about Latham’s Healthcare & Life Sciences industry experience.

Awards & Rankings

  • Latham Recognized with Seven Notable Accolades - September 22, 2020
  • Latham Again Named Washington, D.C. Intellectual Property Litigation Department of the Year - May 27, 2020
  • Healthcare & Life Sciences Partner Recognized as Top Healthcare Lawyer - May 05, 2020
  • San Diego Partner Named Healthcare Trailblazer - April 12, 2020
  • Two Latham Trial Victories Honored Among California’s Top Verdicts - February 26, 2020

Latham has a "strong bench of former government attorneys who field expertise across numerous US departments and offices" and a "dominant presence in qui tam suits and criminal proceedings, as well as frequent involvement in complex transactions, including high-value M&A.”

– Chambers USA 2020

Events

Webcast – FDA Regulatory Updates and 2020 Outlook for Vaping and Cannabis-Derived SubstancesSecurities Enforcement Forum 2019 Webcast: Recent Developments in Health Care Enforcement

Media Coverage

Top 40 Under 40: Amy HargreavesPro VC Health Pulse: Life Sciences Startups Strike Acquisition-Option DealsSkilled in the Art: Two Intellectual Property Wins

News

Latham Advises Underwriters on PMV Pharma’s IPOLatham Recognized with Seven Notable Accolades by LMG Life Sciences Latham & Watkins Advises Odyssey Investment Partners in Acquisition of ProPharma Group

Thought Leadership

UK Issues New Guidance for Medical Device Regulation After BrexitHealthcare AI Deals a Tonic for PE InvestorsCOVID-19: Managing Worker Health & Safety

Webcasts & Podcasts

FDA Regulatory Updates and 2020 Outlook for Vaping and Cannabis-Derived Substances